• Users Online: 24724
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Cobimetinib/vemurafenib
Reactions Weekly.2020;1824(1)100
[DOI]
2Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics
Syeda Samira Afrose,Md. Junaid,Yeasmin Akter,Mousumi Tania,Meiling Zheng,Md. Asaduzzaman Khan
Drug Discovery Today.2020;25(12)2294
[DOI]
3Ocular Toxicity of Targeted Anticancer Agents
Blake H. Fortes,Prashant D. Tailor,Lauren A. Dalvin
Drugs.2021;81(7)771
[DOI]
4Ocular Surface Side Effects of Novel Anticancer Drugs
Livio Vitiello,Filippo Lixi,Giulia Coco,Giuseppe Giannaccare
Cancers.2024;16(2)344
[DOI]
5Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019
Xuetong Chu,Yizhi Bu,Xiaoping Yang
Frontiers in Oncology.2021;11(2)344
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal